Impact of “Time-From-Biopsy-to-Prostatectomy” on Adverse Oncological Results in Patients With Intermediate and High-Risk Prostate Cancer-Reference-Cited by-同舟云学术

Impact of “Time-From-Biopsy-to-Prostatectomy” on Adverse Oncological Results in Patients With Intermediate and High-Risk Prostate Cancer

Published:2020-09-25 Issue: Volume:7 Page:
ISSN:2296-875X
Container-title:Frontiers in Surgery
language:
Short-container-title:Front. Surg.

Author:

Engl Tobias,Mandel Philipp,Hoeh Benedikt,Preisser Felix,Wenzel Mike,Humke Clara,Welte Maria,Köllermann Jens,Wild Peter,Deuker Marina,Kluth Luis A.,Roos Frederik C.,Chun Felix K. H.,Becker Andreas

Publisher

Frontiers Media SA

Subject

Surgery

Reference27 articles.

1. Guidelines Prostate Cancer.2020

2. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer;Sommers;Cancer.,2007

3. Who makes the decision regarding the treatment of clinically localized prostate cancer-the patient or physician? Results from a population-based study;Song;Cancer.,2013

4. Informed decision making: assessment of the quality of physician communication about prostate cancer diagnosis and treatment;Holmes-Rovner;Med Decis Making.,2015

5. Urological oncology. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?;Boorjian;BJU Int.,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time from biopsy to radical prostatectomy by race in an equal‐access healthcare system: Results from the SEARCH cohort;The Prostate;2023-04-25

2. Intraoperative Evaluation and Management of High-Risk Prostate Cancer during Robot-Assisted Radical Prostatectomy;Robotic Urologic Surgery;2022

3. The impact of COVID-19 on surgical volume and surgical training at a high-volume pelvic oncology centre;Urologia Journal;2021-12-08

4. A multi-level spatio-temporal analysis on prostate cancer outcomes;Cancer Epidemiology;2021-06

5. Time pressure predicts decisional regret in men with localized prostate cancer: data from a longitudinal multicenter study;World Journal of Urology;2021-05-22